Trials / Completed
CompletedNCT01864343
Target Temperature Management In Myocardial Infarction - A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal in the treatment of acute myocardial infarction is to reperfuse the ischemic myocardium to reduce infarct size. Animal data and human data suggest that whole-body cooling to temperatures below 35°C before revascularisation can additionally reduce infarct size and therefore improves outcome in these patients. The purpose of the study is to determine the feasibility and safety of a combined cooling strategy started in the out-of-hospital arena for achieving pre-reperfusion hypothermia in patients with acute st-elevation myocardial infarction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EMCOOLS flex pad; Philips Innercool RTx | Surface cooling with EMCOOLS flex pads (out-of-hospital); Infusion of 1000ml to 2000ml of cold saline (out-of-hospital); central-venous cooling (Philips Innercool RTx) |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-04-01
- Completion
- 2013-05-01
- First posted
- 2013-05-29
- Last updated
- 2013-05-29
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01864343. Inclusion in this directory is not an endorsement.